Two Sigma Investments, LP Cyma Bay Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $1,263 - $2,447	-100 Reduced 0.07%	146,189 $3.45 Million
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $7.92 Million - $12.9 Million	-729,599 Reduced 83.3%	146,289 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$7.47 - $10.95 $4.06 Million - $5.95 Million	-543,652 Reduced 38.3%	875,888 $9.59 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $6.06 Million - $9.88 Million	1,030,443 Added 264.83%	1,419,540 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $287,707 - $560,224	89,350 Added 29.81%	389,097 $2.44 Million
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $517,538 - $794,057	186,837 Added 165.47%	299,747 $1.05 Million
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $47,293 - $93,211	27,496 Added 32.19%	112,910 $333,000
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $158,759 - $208,622	57,314 Added 203.96%	85,414 $266,000
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $90,763 - $129,259	28,100 New	28,100 $95,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $941,119 - $1.2 Million	-271,216 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $2.98 Million - $3.72 Million	-756,020 Reduced 73.6%	271,216 $1.18 Million
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $373,259 - $577,978	-88,241 Reduced 7.91%	1,027,236 $4.66 Million
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $4.99 Million - $7.86 Million	870,584 Added 355.5%	1,115,477 $6.4 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $210,408 - $458,842	-63,376 Reduced 20.56%	244,893 $1.77 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $19,449 - $58,624	-13,794 Reduced 4.28%	308,269 $1.08 Million
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $82,806 - $133,814	-66,245 Reduced 17.06%	322,063 $477,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $478,278 - $2.13 Million	359,608 Added 1252.99%	388,308 $761,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $146,944 - $206,927	28,700 New	28,700 $147,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account